Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

Leipzig University

Leipzig, NémetországeducationHonlap

Más néven: Universitaet Leipzig · University of Leipzig · Universität Leipzig

203futó vizsgálat
76lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
NCT07335562· 3. fázis· Forrás
Még nem toboroz
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
NCT07291102· 3. fázis· Forrás
Még nem toboroz
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR
2024-517295-37-00· 3. fázis· Forrás
Toboroz
Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations
NCT07789574· 2. fázis· Forrás
Még nem toboroz
A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.
2026-525367-40-00· 3. fázis· Forrás
Még nem toboroz
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
NCT07861100· 3. fázis· Forrás
Toboroz
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07465289· 3. fázis· Forrás
Még nem toboroz
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
NCT07719348· 1/2. fázis· Forrás
Toboroz
A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.
2025-523285-25-00· 3. fázis· Forrás
Toboroz
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
2025-525016-41-00· 2. fázis· Forrás
Toboroz
A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
NCT07807163· 2. fázis· Forrás
Még nem toboroz
AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
2025-522190-11-01· 3. fázis· Forrás
Még nem toboroz
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
2026-525883-17-00· 3. fázis· Forrás
Toboroz
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300· 3. fázis· Forrás
Toboroz
BGB-43395 in Combination with Letrozole versus CDK4/6i with Letrozole for Patients with Previously Untreated Advanced or Metastatic HR+/HER2- Breast Cancer
NCT07492641· 3. fázis· Forrás
Toboroz
A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma
2025-523815-12-00· 3. fázis· Forrás
Toboroz
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT07690371· 3. fázis· Forrás
Toboroz
Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
NCT07843927· 3. fázis· Forrás
Toboroz
PREFer
NCT06916416· 2. fázis· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07463521· 3. fázis· Forrás
Még nem toboroz
A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
2025-524014-29-00· 3. fázis· Forrás
Toboroz
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412· 3. fázis· Forrás
Toboroz
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
2025-521546-23-00· 3. fázis· Forrás
Toboroz
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
2024-519818-31-01· 3. fázis· Forrás
Toboroz
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
NCT07355218· 3. fázis· Forrás
Toboroz
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
NCT07299019· 3. fázis· Forrás
Toboroz
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
NCT07067463· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT07221149· 2/3. fázis· Forrás
Toboroz
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants
2025-521762-99-00· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
NCT07409272· 3. fázis· Forrás
Toboroz
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558· 3. fázis· Forrás
Toboroz
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
NCT07431281· 3. fázis· Forrás
Toboroz
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
NCT06875128· 2. fázis· Forrás
Toboroz
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703· 3. fázis· Forrás
Toboroz
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
NCT07325292· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· 2/3. fázis· Forrás
Toboroz
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809· 3. fázis· Forrás
Fut, nem toboroz
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
NCT07277660· 2. fázis· Forrás
Toboroz
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.
2024-512503-39-00· 4. fázis· Forrás
Fut, nem toboroz
A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038)
2025-521970-33-00· 3. fázis· Forrás
Toboroz
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
NCT07280585· 3. fázis· Forrás
Toboroz
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT07221188· 3. fázis· Forrás
Toboroz
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800· 3. fázis· Forrás
Toboroz
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
NCT06804161· 3. fázis· Forrás
Toboroz
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
NCT07276399· 3. fázis· Forrás
Toboroz
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
NCT07211958· 3. fázis· Forrás
Toboroz
A Phase II, Open-Label, Single-Center, Single-Arm Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Blinatumomab for Treatment of Patients with Autoimmune B-Cell driven Diseases including Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) and Granulomatous Polyangiitis (GPA), BlinA-B trial
2025-523061-22-00· 2. fázis· Forrás
Fut, nem toboroz
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150· 3. fázis· Forrás
Toboroz
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080· 3. fázis· Forrás
Toboroz
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
NCT07026474· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Gyermekkori daganatok18 toboroz
Akut mieloid leukémia (AML)10 toboroz
Mielodiszplasztikus szindróma (MDS)8 toboroz
Mielóma multiplex7 toboroz
Vastagbélrák7 toboroz
Fej-nyaki daganatok6 toboroz
Gyomor- és nyelőcsőrák6 toboroz
Akut limfoid leukémia (ALL)5 toboroz
Áttétes emlőrák5 toboroz
Krónikus mieloid leukémia (CML)5 toboroz
Máj- és epeúti rák5 toboroz
Méhtestrák5 toboroz
Petefészekrák5 toboroz
Tüdőrák5 toboroz
Depresszió4 toboroz
Hasnyálmirigyrák4 toboroz
Méhnyakrák4 toboroz
Melanóma4 toboroz
Sclerosis multiplex (SM)4 toboroz
Szarkóma4 toboroz
Krónikus limfoid leukémia (CLL)3 toboroz
Lupus (SLE)3 toboroz
Myasthenia gravis3 toboroz
Parkinson-kór3 toboroz
Stroke (szélütés)3 toboroz
Zsírmáj (MASLD/MASH)3 toboroz
Elhízás2 toboroz
Glioblasztóma2 toboroz
Mieloproliferatív neopláziák2 toboroz
Policisztás vesebetegség2 toboroz
Szisztémás szklerózis (szkleroderma)2 toboroz
Tripla negatív emlőrák2 toboroz
Alzheimer-kór1 toboroz
Amiloidózis1 toboroz
Atópiás dermatitisz (ekcéma)1 toboroz
Colitis ulcerosa1 toboroz
Diabéteszes retinopátia1 toboroz
Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
Follikuláris limfóma1 toboroz
HIV-fertőzés1 toboroz
Hodgkin-limfóma1 toboroz
Hólyagrák1 toboroz
Huntington-kór1 toboroz
Idiopátiás tüdőfibrózis1 toboroz
Időskori makuladegeneráció1 toboroz
IgA-nefropátia1 toboroz
Köpenysejtes limfóma1 toboroz
Magas vérnyomás1 toboroz
Mezotelióma1 toboroz
Neuroblasztóma1 toboroz
Pitvarfibrilláció1 toboroz
Primer biliáris cholangitis (PBC)1 toboroz
Prosztatarák1 toboroz
Szívelégtelenség1 toboroz
Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
Essentiale® liquid once-daily Phase III study
2025-521678-32-00· 3. fázis· Forrás
Fut, nem toboroz
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC)
2024-517818-15-00· 1/2. fázis· Forrás
Lezárult
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
2024-518364-12-00· 2. fázis· Forrás
Fut, nem toboroz
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884· 2. fázis· Forrás
Lezárult
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
NCT06433219· 2. fázis· Forrás
Fut, nem toboroz
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
NCT06243458· 2. fázis· Forrás
Lezárult
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT06335303· 2. fázis· Forrás
Lezárult
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· 2/3. fázis· Forrás
Lezárult
“A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis”
2023-503289-22-00· 2. fázis· Forrás
Lezárult
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
NCT06430671· 1. fázis· Forrás
Fut, nem toboroz
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06082167· 2/3. fázis· Forrás
Lezárult
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1
NCT05870748· 2. fázis· Forrás
Fut, nem toboroz
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
NCT06346067· 3. fázis· Forrás
Lezárult
Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis
NCT05984784· 1/2. fázis· Forrás
Lezárult
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).
NCT05975905· 2. fázis· Forrás
Lezárult
A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 β/γ, or Pembrolizumab Monotherapy as Neoadjuvant Therapy in Participants with Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
2023-506092-10-00· 2. fázis· Forrás
Lezárult
A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
2023-509472-42-00· 3. fázis· Forrás
Leállították
IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack
NCT06139328· 2. fázis· Forrás
Lezárult
CA-4948-104: A Ph1 Study of Emavusertib in AML CR MRD+ Patients Currently Receiving Azacitidine and Venetoclax
2023-505828-58-00· 1. fázis· Forrás
Lezárult
A Study to Evaluate Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or Refractory Multiple Myeloma
2023-503689-21-00· 1/2. fázis· Forrás
Lezárult
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
NCT06056505· Forrás
Lezárult
A Study to Investigate MBS2320 Patients with IPF
2023-504418-30-00· 2. fázis· Forrás
Fut, nem toboroz
Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE
2022-502105-15-00· 2. fázis· Forrás
Lezárult
Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)
2022-502040-13-00· 2. fázis· Forrás
Lezárult
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
NCT05923099· 2. fázis· Forrás
Lezárult
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
NCT05882734· 1/2. fázis· Forrás
Lezárult
Clinical trial of MK-7648A in adults and children with skin cancer
NCT05665595· 3. fázis· Forrás
Lezárult
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· 2. fázis· Forrás
Lezárult
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
2024-512646-42-00· 2. fázis· Forrás
Fut, nem toboroz
Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy
NCT05833438· 2. fázis· Forrás
Lezárult
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05767021· 3. fázis· Forrás
Lezárult
A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
NCT07304843· 1/2. fázis· Forrás
Lezárult
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT05811351· 2. fázis· Forrás
Fut, nem toboroz
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
NCT05201066· 2. fázis· Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Forrás
Lezárult
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION)
2023-508528-36-00· 3. fázis· Forrás
Fut, nem toboroz
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
NCT05567796· 3. fázis· Forrás
Lezárult
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
NCT05508867· 2. fázis· Forrás
Lezárult
Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102)
NCT05111626· 3. fázis· Forrás
Lezárult
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients.
NCT04811092· 3. fázis· Forrás
Lezárult
Tiotropium in preventing preschool asthma (TIPP)
2024-513916-84-00· 3. fázis· Forrás
Fut, nem toboroz
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Inoperable or Metastatic Hormone Receptor-positive, HER2-negative Breast Cancer
NCT05104866· 3. fázis· Forrás
Fut, nem toboroz
Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
NCT05182385· 1/2. fázis· Forrás
Lezárult
Study to Evaluate the Long-Term Efficacy and Safety of the Investigational Drug LIB003 for the Reduction of Cholesterol in Patients with Homozygous and Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease, or at High Risk for Cardiovascular Disease.
NCT04798430· 3. fázis· Forrás
Lezárult
An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1)
2024-512717-41-00· 2. fázis· Forrás
Lezárult
A Long-term Follow-up Study of Sotatercept for PAH Treatment
NCT04796337· 3. fázis· Forrás
Lezárult
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
NCT04732221· 2/3. fázis· Forrás
Lezárult
A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
NCT04526899· 2. fázis· Forrás
Lezárult
RegoNivo vs Standard of Care Chemotherapy in AGOC
NCT04879368· 3. fázis· Forrás

Vizsgálati helyszínek

Department of Head Medicine and Oral Health, University of Leipzig1 vizsgálat
Leipzig University, Department of Urology1 vizsgálat
Universitaet Leipzig262 vizsgálat
Universität Leipzig4 vizsgálat
University Leipzig, Department of Psychiatry and Psychotherapy1 vizsgálat
University of Leipzig17 vizsgálat
University of Leipzig, Dept. Psychiatry and Psychotherapy1 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Elhízás117 munka · 7 vizsgálat
Krónikus mieloid leukémia (CML)5 munka · 9 vizsgálat

Intézményadatok: ROR 03s7gtk40 (CC0-1.0)Frissítve: 2026. nov. 10.